OVERVIEW
Evocati partners with founders and CEOs to build growth plans for their business. These growth plans are tailored specifically to each company but leverage our experience in the industries we target. Over the past 15 years, the life science tools industry has changed dramatically, with the largest change being industry consolidation. It has become harder to stand-out amongst customers and acquirers, even for products with excellent performance or teams with industry-leading subject matter expertise. Our goal is to partner to change that. Our team has direct experience bringing scale to tools businesses: via M&A support, international expansion structuring, product expansion in to higher growth markets, building sales plans for high-value, repeat pharma business, or e-commerce optimization. We also bring a network of top talent that supports these efforts and recruits top employees to the company, so these efforts are sustainable
Acquire the business
We have capital to acquire businesses and invest to scale them. You can sell your business to Evocati knowing that we have a plan to build on the technical foundation you have built, and a team that won’t damage the trusted name you have built with the scientific community.
Partner to recapitalize the business
For owners that would like to stay invested, we can acquire a portion of the equity, leaving the former owners with upside for the growth plan ahead, and bring new capital and a growth plan, so both new and legacy ownership can benefit from the scale, and larger exit valuation, we expect after we deliver our plan. This is the preferred structure we use that has the best results for incentive alignment and joint benefit.
Targeted growth strategy partnership
In select situations, we can work on a single growth project that is usually part of a growth plan and execute that project in exchange for equity or other compensation. Whether it is helping with a select M&A deal, standing up an e-commerce platform, or building a global distributor network, we have helped CEOs with select projects when a sale of the company is not being contemplated. It is not our preferred structure, but an option to discuss.
